244 related articles for article (PubMed ID: 22114551)
1. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.
Semighini CP; Averette AF; Perfect JR; Heitman J
PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
[TBL] [Abstract][Full Text] [Related]
4. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.
Sionov E; Lee H; Chang YC; Kwon-Chung KJ
PLoS Pathog; 2010 Apr; 6(4):e1000848. PubMed ID: 20368972
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans.
Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
PLoS One; 2012; 7(3):e33022. PubMed ID: 22412978
[TBL] [Abstract][Full Text] [Related]
7. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
Sionov E; Chang YC; Garraffo HM; Kwon-Chung KJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2804-15. PubMed ID: 19414582
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
Paul S; Doering TL; Moye-Rowley WS
Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
[TBL] [Abstract][Full Text] [Related]
9. Colony and Single Cell Level Analysis of the Heterogeneous Response of
Altamirano S; Simmons C; Kozubowski L
Front Cell Infect Microbiol; 2018; 8():203. PubMed ID: 29971221
[No Abstract] [Full Text] [Related]
10. Unisexual and heterosexual meiotic reproduction generate aneuploidy and phenotypic diversity de novo in the yeast Cryptococcus neoformans.
Ni M; Feretzaki M; Li W; Floyd-Averette A; Mieczkowski P; Dietrich FS; Heitman J
PLoS Biol; 2013 Sep; 11(9):e1001653. PubMed ID: 24058295
[TBL] [Abstract][Full Text] [Related]
11. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.
Stone NR; Rhodes J; Fisher MC; Mfinanga S; Kivuyo S; Rugemalila J; Segal ES; Needleman L; Molloy SF; Kwon-Chung J; Harrison TS; Hope W; Berman J; Bicanic T
J Clin Invest; 2019 Mar; 129(3):999-1014. PubMed ID: 30688656
[TBL] [Abstract][Full Text] [Related]
12. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
13. Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B.
Carlson T; Lupinacci E; Moseley K; Chandrasekaran S
FEMS Microbiol Lett; 2021 May; 368(7):. PubMed ID: 33877319
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A.
Florio AR; Ferrari S; De Carolis E; Torelli R; Fadda G; Sanguinetti M; Sanglard D; Posteraro B
BMC Microbiol; 2011 May; 11():97. PubMed ID: 21569340
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Khyriem AB; Sujatha S; Parija SC
Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
[TBL] [Abstract][Full Text] [Related]
16. Physiological Differences in Cryptococcus neoformans Strains
Grossman NT; Casadevall A
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031206
[No Abstract] [Full Text] [Related]
17. Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil.
Moreira IMB; Cortez ACA; de Souza ÉS; Pinheiro SB; de Souza Oliveira JG; Sadahiro A; Cruz KS; Matsuura ABJ; Melhem MSC; Frickmann H; de Souza JVB
Med Mycol; 2022 Mar; 60(3):. PubMed ID: 35084497
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
[TBL] [Abstract][Full Text] [Related]
19. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
20. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
